Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

VJOncology

healthcare data technology

Quarter of UK patients now diagnosing online

Survey finds people would rather self-diagnose symptoms than wait for GP appointment

- PMLiVE

Teva buys Allergan generics unit for $40.5bn

Will now drop its six-month pursuit of Mylan

- PMLiVE

EATRIS and the new age of partnering

Anton Ussi on the institute's long-term plans

EU flag

Shire and Baxalta drugs among CHMP’s latest recommendations

New drugs for ADHD and haemophilia backed forEuropean approval

RRD International hires Ulrich Thienel as CDMO

Company expands leadership team with former Takeda VP

- PMLiVE

Sanofi’s cholesterol drug Praluent backed for European approval

CHMPdecision puts firm on-course to catch up with Amgen's Repatha

Biogen’s Douglas Williams departs for biotech start-up

Research head will be first member of a new cancer-focused firm

- PMLiVE

FDA approves four new medicines across multiple areas

Sanofi/Regeneron, BMS, AbbVie and Novartis all chalk up major approvals

AstraZeneca AZ

AZ sells rare cancer drug to Sanofi

French firm’s rare disease unit Genzyme will pay $300m for the treatment

- PMLiVE

Thirty years of training excellence and innovation

Excel Communications reflects on its development over the last three decades

- PMLiVE

Jobs to do

Identifying opportunities and taking advantage of them

- PMLiVE

AstraZeneca forms ‘smart inhaler’ digital health partnership

Follows separate deal for a health coaching app for heart attack patients

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links